ArticleRheumatology and therapy2023

Clinical Outcomes in Patients with Rheumatoid Arthritis After Switching Between Interleukin-6-Receptor Inhibitors and Janus Kinase Inhibitors: Findings from an Observational Study.

Anisha B Dua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.